The Company may be the first to offer an all-natural ‘cancer cocktail’ combining the therapeutic benefits of the plant and animal kingdoms PR Newswire, PTLF HANCOCK, Maryland, June 14, 2017 HANCOCK, Maryland, June 14, 2017 /PRNewswire/ — PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the “Company”), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, reports on its solution to the ever increasing problem of drug resistance and high toxicity in the treatment of cancer inRead more
- How to Choose the Right Cryptocurrency to Invest in 2018
- mCig’s Subsidiary, Grow Contractors Inc., Announces it has Secured an Exclusive Management Contract in Sacramento, CA, Paving the Way to an Expanded Presence in the State
- MoneyTV with Donald Baillargeon, 4/20
- Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR
- NutraFuels, Inc. (NTFU) Provides 2017 Year End Financials Revenues Increase 694.6%
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More